Yongxin Biomedical signed an MOU with Jianyi Biotechnology to create an ADC industry value chain
KriSan Biotech Launched its GMP Oligonucleotides
Vectura Group plc has signed an agreement with Monash University’s Institute of Pharmaceutical Sciences (MIPS), to develop inhaled oxytocin delivered via a dry powder inhaler to prevent postpartum hemorrhage (PPH) in childbirth. An inhaled formulation of oxytocin, currently administered via injection, is expected to provide important advantages including ease of use, rapid onset of action and safe storage outside of the cold chain. Vectura will receive undisclosed revenues on a fee-for-service basis.
Contract development and manufacturing organisation (CDMO), nSamsung Biologics, and AstraZeneca, continue their strategic ncollaboration which was initiated in May 2021.
GS Krishnan, formerly regional president & MD, Novozymes South Asia Pvt Ltd, a Danish biotech company, has taken charge as the new President of India's leading biotechnology industry organisation, the Association of Biotechnology-Led Enterprises (ABLE). Kiran Mazumdar-Shaw, the Executive Chairperson of Biocon Limited, will continue as the association's honorary non-executive chairperson, an ABLE statement said.